252 related articles for article (PubMed ID: 8824542)
1. Growth features of aberrant crypt foci that resist modulation by cholic acid.
Shirtliff N; Bird RP
Carcinogenesis; 1996 Sep; 17(9):2093-6. PubMed ID: 8824542
[TBL] [Abstract][Full Text] [Related]
2. Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid.
Magnuson BA; Carr I; Bird RP
Cancer Res; 1993 Oct; 53(19):4499-504. PubMed ID: 8402621
[TBL] [Abstract][Full Text] [Related]
3. Reduction of aberrant crypt foci induced in rat colon with azoxymethane or methylnitrosourea by feeding cholic acid.
Magnuson BA; Bird RP
Cancer Lett; 1993 Jan; 68(1):15-23. PubMed ID: 8422645
[TBL] [Abstract][Full Text] [Related]
4. Further investigation of the effect of cholic acid on the induction, growth characteristics and stability of aberrant crypt foci in rat colon.
Bird RP
Cancer Lett; 1995 Jan; 88(2):201-9. PubMed ID: 7874694
[TBL] [Abstract][Full Text] [Related]
5. Resistance of aberrant crypt foci to apoptosis induced by azoxymethane in rats chronically fed cholic acid.
Magnuson BA; Shirtliff N; Bird RP
Carcinogenesis; 1994 Jul; 15(7):1459-62. PubMed ID: 8033325
[TBL] [Abstract][Full Text] [Related]
6. Tumor-enhancing effects of cholic acid are exerted on the early stages of colon carcinogenesis via induction of aberrant crypt foci with an enhanced growth phenotype.
Baijal PK; Clow EP; Fitzpatrick DW; Bird RP
Can J Physiol Pharmacol; 1998 Dec; 76(12):1095-102. PubMed ID: 10326831
[TBL] [Abstract][Full Text] [Related]
7. Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis.
Femia AP; Dolara P; Caderni G
Carcinogenesis; 2004 Feb; 25(2):277-81. PubMed ID: 14604897
[TBL] [Abstract][Full Text] [Related]
8. Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats.
Challa A; Rao DR; Chawan CB; Shackelford L
Carcinogenesis; 1997 Mar; 18(3):517-21. PubMed ID: 9067551
[TBL] [Abstract][Full Text] [Related]
9. Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis.
Hirose Y; Kuno T; Yamada Y; Sakata K; Katayama M; Yoshida K; Qiao Z; Hata K; Yoshimi N; Mori H
Carcinogenesis; 2003 Jan; 24(1):107-11. PubMed ID: 12538355
[TBL] [Abstract][Full Text] [Related]
10. Modulation of aberrant crypt foci by dietary fat and caloric restriction: the effects of delayed intervention.
Lasko CM; Bird RP
Cancer Epidemiol Biomarkers Prev; 1995; 4(1):49-55. PubMed ID: 7894324
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor.
Rao CV; Kawamori T; Hamid R; Reddy BS
Carcinogenesis; 1999 Apr; 20(4):641-4. PubMed ID: 10223193
[TBL] [Abstract][Full Text] [Related]
12. Dietary n-3 PUFA increases the apoptotic response to 1,2-dimethylhydrazine, reduces mitosis and suppresses the induction of carcinogenesis in the rat colon.
Latham P; Lund EK; Johnson IT
Carcinogenesis; 1999 Apr; 20(4):645-50. PubMed ID: 10223194
[TBL] [Abstract][Full Text] [Related]
13. Suppression of azoxymethane-induced colonic aberrant crypt foci by a nitric oxide synthase inhibitor.
Kawamori T; Takahashi M; Watanabe K; Ohta T; Nakatsugi S; Sugimura T; Wakabayashi K
Cancer Lett; 2000 Jan; 148(1):33-7. PubMed ID: 10680590
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of azoxymethane-induced rat aberrant crypt foci by dietary zerumbone isolated from Zingiber zerumbet.
Tanaka T; Shimizu M; Kohno H; Yoshitani S; Tsukio Y; Murakami A; Safitri R; Takahashi D; Yamamoto K; Koshimizu K; Ohigashi H; Mori H
Life Sci; 2001 Sep; 69(16):1935-45. PubMed ID: 11693274
[TBL] [Abstract][Full Text] [Related]
15. Colon tumor promotion: is it a selective process? Effects of cholate, phytate, and food restriction in rats on proliferation and apoptosis in normal and aberrant crypts.
Corpet DE; Taché S; Peiffer G
Cancer Lett; 1997 Mar; 114(1-2):135-8. PubMed ID: 9103272
[TBL] [Abstract][Full Text] [Related]
16. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer.
Bird RP
Cancer Lett; 1995 Jun; 93(1):55-71. PubMed ID: 7600544
[TBL] [Abstract][Full Text] [Related]
17. Effects of resistant starch on colonic preneoplastic aberrant crypt foci in rats.
Liu R; Xu G
Food Chem Toxicol; 2008 Aug; 46(8):2672-9. PubMed ID: 18571825
[TBL] [Abstract][Full Text] [Related]
18. Aberrant crypt foci in the colonic mucosa of rats treated with a genotoxic and nongenotoxic colon carcinogen.
Whiteley LO; Hudson L; Pretlow TP
Toxicol Pathol; 1996; 24(6):681-9. PubMed ID: 8994294
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of colon carcinogenesis by post-initiation induction of NQO1 in Sprague-Dawley rats.
Begleiter A; Sivananthan K; Lefas GM; Maksymiuk AW; Bird RP
Oncol Rep; 2009 Jun; 21(6):1559-65. PubMed ID: 19424637
[TBL] [Abstract][Full Text] [Related]
20. Conjugated linoleic acid does not inhibit development of aberrant crypt foci in colons of male Sprague-Dawley rats.
Ealey KN; el-Sohemy A; Archer MC
Nutr Cancer; 2001; 41(1-2):104-6. PubMed ID: 12094611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
